Recent Finacing
Recent Raise
Thetis Pharmaceuticals is a clinical-stage drug developer creating oral small-molecule therapies, including TP-317 targeting the LTB4-BLT1 pathway for IBD and TP101 for type 2 diabetes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Thetis Pharmaceuticals.
